Surveillance epidemiology and end results analysis demonstrates improvement in overall survival for cervical cancer patients treated in the era of concurrent chemoradiotherapy.

Hsu, Howard C; Li, Xiaochun; Curtin, John P; Goldberg, Judith D; Schiff, Peter B

Hsu, Howard C; Li, Xiaochun; Curtin, John P; Goldberg, Judith D; Schiff, Peter B.

Afiliação

Hsu HC; Department of Radiation Oncology, New York University School of Medicine , New York, NY , USA.
Li X; Department of Population Health, Division of Biostatistics, New York University School of Medicine , New York, NY , USA.
Curtin JP; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York University School of Medicine , New York, NY , USA.
Goldberg JD; Department of Population Health, Division of Biostatistics, New York University School of Medicine , New York, NY , USA.
Schiff PB; Department of Radiation Oncology, New York University School of Medicine , New York, NY , USA.

Front Oncol ; 5: 81, 2015.

Article em En | MEDLINE | ID: mdl-25918687

Palavras-chave

SEER; cervical cancer; chemotherapy; radiotherapy; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Screening_studies Idioma: En Revista: Front Oncol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google